Overview
Paul Richardson is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Richardson is rated as a Distinguished provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft.
His clinical research consists of co-authoring 669 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Agranulocytosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- MEDICARE MAPD
- OTHER MEDICARE
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Avenue, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Massachusetts General Physicians Organization Inc
Jeremy Abramson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Abramson is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Matthew Davids is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Davids is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Tissue Biopsy, and Bone Marrow Transplant. Dr. Davids is currently accepting new patients.
Dana-Farber Cancer Institute, Breast Oncology Program
Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School. She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer. She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials. Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Agranulocytosis. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bone Marrow TransplantDr. Richardson isElite. Learn about Bone Marrow Transplant.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Multiple MyelomaDr. Richardson isElite. Learn about Multiple Myeloma.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Richardson isElite. Learn about Smoldering Multiple Myeloma.
- Distinguished
- AgranulocytosisDr. Richardson isDistinguished. Learn about Agranulocytosis.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- PlasmacytomaDr. Richardson isDistinguished. Learn about Plasmacytoma.
- Schnitzler SyndromeDr. Richardson isDistinguished. Learn about Schnitzler Syndrome.
- ThrombocytopeniaDr. Richardson isDistinguished. Learn about Thrombocytopenia.
- Waldenstrom MacroglobulinemiaDr. Richardson isDistinguished. Learn about Waldenstrom Macroglobulinemia.
- Advanced
- Febrile NeutropeniaDr. Richardson isAdvanced. Learn about Febrile Neutropenia.
- Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency
- GTP Cyclohydrolase 1 DeficiencyDr. Richardson isAdvanced. Learn about GTP Cyclohydrolase 1 Deficiency.
- HypophosphatemiaDr. Richardson isAdvanced. Learn about Hypophosphatemia.
- LeukemiaDr. Richardson isAdvanced. Learn about Leukemia.
- Osteolysis Syndrome RecessiveDr. Richardson isAdvanced. Learn about Osteolysis Syndrome Recessive.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Richardson isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AnemiaDr. Richardson isExperienced. Learn about Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Richardson isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- Blood ClotsDr. Richardson isExperienced. Learn about Blood Clots.
- Bone GraftDr. Richardson isExperienced. Learn about Bone Graft.
- Bone TumorDr. Richardson isExperienced. Learn about Bone Tumor.